Allicin, an Emerging Treatment for Pulmonary Arterial Hypertension: An Experimental Study

We assessed whether allicin, through its antihypertensive and antioxidant effects, relieves vascular remodeling, endothelial function, and oxidative stress (OS), thereby improving experimental pulmonary arterial hypertension (PAH). Allicin (16 mg/kg) was administered to rats with PAH (monocrotaline...

Descripción completa

Detalles Bibliográficos
Autores principales: Sánchez-Gloria, José L., Martínez-Olivares, Constanza E., Del Valle-Mondragón, Leonardo, Cortés-Camacho, Fernando, Zambrano-Vásquez, Oscar R., Hernández-Pando, Rogelio, Sánchez-Muñoz, Fausto, Sánchez-Lozada, Laura G., Osorio-Alonso, Horacio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10454707/
https://www.ncbi.nlm.nih.gov/pubmed/37629140
http://dx.doi.org/10.3390/ijms241612959

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10454707/
https://www.ncbi.nlm.nih.gov/pubmed/37629140
http://dx.doi.org/10.3390/ijms241612959

Ejemplares similares